217 related articles for article (PubMed ID: 18663578)
1. Nanotechnology for breast cancer therapy.
Tanaka T; Decuzzi P; Cristofanilli M; Sakamoto JH; Tasciotti E; Robertson FM; Ferrari M
Biomed Microdevices; 2009 Feb; 11(1):49-63. PubMed ID: 18663578
[TBL] [Abstract][Full Text] [Related]
2. Applied nanotechnology for the management of breakthrough cancer pain.
Sprintz M; Benedetti C; Ferrari M
Minerva Anestesiol; 2005; 71(7-8):419-23. PubMed ID: 16012414
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology for sensing, imaging, and treating cancer.
Panchapakesan B; Wickstrom E
Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
Parhi P; Mohanty C; Sahoo SK
Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
[TBL] [Abstract][Full Text] [Related]
6. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
Steinberg M
Clin Ther; 2008 Sep; 30(9):1590-617. PubMed ID: 18840366
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
8. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant therapies: the example of breast cancer].
Bachelot T; Guastalla JP; Ray-Coquard I
Rev Prat; 2008 Apr; 58(8):817-9. PubMed ID: 18630815
[TBL] [Abstract][Full Text] [Related]
10. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
Gligorov J; Lotz JP
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
[TBL] [Abstract][Full Text] [Related]
11. The promise of nanotechnology for solving clinical problems in breast cancer.
Grobmyer SR; Morse DL; Fletcher B; Gutwein LG; Sharma P; Krishna V; Frost SC; Moudgil BM; Brown SC
J Surg Oncol; 2011 Mar; 103(4):317-25. PubMed ID: 21337565
[TBL] [Abstract][Full Text] [Related]
12. Impact of nanotechnology in breast cancer.
Haq AI; Zabkiewicz C; Grange P; Arya M
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1021-4. PubMed ID: 19671020
[No Abstract] [Full Text] [Related]
13. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology blooms, at last (Review).
Gordon EM; Hall FL
Oncol Rep; 2005 Jun; 13(6):1003-7. PubMed ID: 15870914
[TBL] [Abstract][Full Text] [Related]
15. Improving decision-making in early breast cancer: who to treat and how?
Llombart-Cussac A
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle characterization for cancer nanotechnology and other biological applications.
Brown SC; Palazuelos M; Sharma P; Powers KW; Roberts SM; Grobmyer SR; Moudgil BM
Methods Mol Biol; 2010; 624():39-65. PubMed ID: 20217588
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnological applications for the treatment of neurodegenerative disorders.
Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer.
Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
[TBL] [Abstract][Full Text] [Related]
19. Molecular underpinnings of the targeted therapy for cancer.
Wcisło G
Acta Pol Pharm; 2008; 65(6):633-40. PubMed ID: 19172844
[TBL] [Abstract][Full Text] [Related]
20. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
